title: [Evaluation of the effectiveness of Vepeside (VP-16-213) in the treatment of drug-resistant recurrences of malignant lymphatic neoplasms].
authors.forename: E
authors.initials: E
authors.lastname: Sliz
authors.forename: M
authors.initials: M
authors.lastname: Pawlicki
authors.forename: B
authors.initials: B
authors.lastname: Zuchowska-Vogelgesang
mesh_terms: D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D005047:Etoposide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence
chemical_list: D005047:Etoposide
vernacular_title: Ocena skuteczności Vepesidu (VP-16-213) w leczeniu chemioopornych nawrotów złośliwych nowotworów limfatycznych.